Salmonella enterica subsp. enterica serovar Newport str. SL254

Names Salmonella enterica subsp. enterica serovar Newport str. SL254
Accession numbers NC_009140, NC_011079, NC_011080
Background Salmonella enterica subsp. enterica serovar Newport. Salmonella enterica subsp. enterica serovar Newport is common worldwide. Outbreak investigations and targeted studies have identified dairy cattle as the main reservoir this serotype. Antimicrobial resistance (Newport MDR-AmpC) is particularly problematic in this serotype, and the prevalence of Newport MDR-AmpC isolates from humans in the United States has increased from 0% during 1996-1997 to 26% in 2001. MDR strains have been recorded as resistant to ampicillin, chloramphenicol, streptomycin, sulphonamides and tetracycline (ACSSuT) and many of these strains show intermediate or full resistance to third-generation cephalosporins, kanamycin, potentiated sulphonamides, and gentamicin. Salmonella enterica subsp. enterica serovar Newport str SL254. The SL254 strain is an MDR strain from one of two distinct lineages of the Newport serovar. (NCBI BioProject: bp_list[1])
Strain SL254
Complete Yes
Sequencing centre (08-JUL-2008) J. Craig Venter Institute, 9704 Medical Center Drive, Rockville, MD 20850, USA
(25-JUL-2008) National Center for Biotechnology Information, NIH, Bethesda, MD 20894, USA
Sequencing quality Level 6: Finished
Sequencing depth NA
Sequencing method NA
Isolation site 1940s by Lilleengen
Isolation country NA
Number of replicons 3
Gram staining properties Negative
Shape Bacilli
Mobility Yes
Flagellar presence NA
Number of membranes NA
Oxygen requirements Facultative
Optimal temperature NA
Temperature range Mesophilic
Habitat Multiple
Biotic relationship Free living
Host name Homo sapiens
Cell arrangement Pairs, Singles
Sporulation Nonsporulating
Metabolism NA
Energy source Chemoorganotroph
Diseases Gastroenteritis
Pathogenicity Yes